Are expensive vaccines the best investment in low-income and middle-income countries?

Lone Simonsen^*, Maarten van Wijhe, Robert Jackson Taylor

^*Corresponding author

Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › peer review

Originalsprog	Engelsk
Tidsskrift	The Lancet Global Health
Vol/bind	7
Udgave nummer	5
Sider (fra-til)	e548-e549
ISSN	2214-109X
DOI	https://doi.org/10.1016/S2214-109X(19)30040-3
Status	Udgivet - 1 maj 2019

Link til dokument

10.1016/S2214-109X(19)30040-3Licens: CC BY

Are expensive vaccines the best investment in low-income and middle-income countries?Forlagets udgivne version, 66,4 KBLicens: CC BY

Citer dette

@article{5070d0962ed04cea8dfbf181063ebb92,

title = "Are expensive vaccines the best investment in low-income and middle-income countries?",

author = "Lone Simonsen and {van Wijhe}, Maarten and Taylor, {Robert Jackson}",

year = "2019",

month = may,

day = "1",

doi = "10.1016/S2214-109X(19)30040-3",

language = "English",

volume = "7",

pages = "e548--e549",

journal = "The Lancet Global Health",

issn = "2214-109X",

publisher = "The Lancet Publishing Group",

number = "5",

}

TY - JOUR

T1 - Are expensive vaccines the best investment in low-income and middle-income countries?

AU - Simonsen, Lone

AU - van Wijhe, Maarten

AU - Taylor, Robert Jackson

PY - 2019/5/1

Y1 - 2019/5/1

U2 - 10.1016/S2214-109X(19)30040-3

DO - 10.1016/S2214-109X(19)30040-3

M3 - Comment/debate

SN - 2214-109X

VL - 7

SP - e548-e549

JO - The Lancet Global Health

JF - The Lancet Global Health

IS - 5

ER -